These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12932249)

  • 21. Skin reaction in antiviral therapy for chronic hepatitis C: a role for polyethylene glycol interferon?
    Cottoni F; Bolognini S; Deplano A; Garrucciu G; Manzoni NE; Careddu GF; Montesu MA; Tocco A; Lissia A; Solinas A
    Acta Derm Venereol; 2004; 84(2):120-3. PubMed ID: 15206691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
    Tavakoli-Tabasi S; Bagree A
    J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis.
    Dalekos GN; Christodoulou D; Kistis KG; Zervou EK; Hatzis J; Tsianos EV
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Kartal ED; Alpat SN; Ozgunes I; Usluer G
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):817-20. PubMed ID: 17700271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
    Castellanos González M; Pérez Carreras M; Muñoz Gómez R; Castellano Tortajada G
    Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
    [No Abstract]   [Full Text] [Related]  

  • 28. Allergic sensitization to pegylated interferon-α results in drug eruptions.
    Meller S; Gerber PA; Kislat A; Hevezi P; Göbel T; Wiesner U; Kellermann S; Bünemann E; Zlotnik A; Häussinger D; Erhardt A; Homey B
    Allergy; 2015 Jul; 70(7):775-83. PubMed ID: 25831972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lingual hyperpigmentation in a patient with chronic infection].
    López Peláez MV; González Díaz P; Téllez Molina MJ; Vergas García J
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):264-5. PubMed ID: 23260387
    [No Abstract]   [Full Text] [Related]  

  • 30. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
    Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
    Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
    [No Abstract]   [Full Text] [Related]  

  • 31. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C.
    Monteagudo B; Grueiro MC; Vilas-Sueiro A; Campo-Cerecedo F
    Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):871-873. PubMed ID: 31387690
    [No Abstract]   [Full Text] [Related]  

  • 33. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.
    Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N
    Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutaneous reactions to interferon and ribavirin.
    Chamberlain AJ; Poon E
    Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1233-40. PubMed ID: 22098185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interferon-alpha and hepatitis C virus: the skin matters].
    Floristán U; Feltes R; Ramírez-Marín P; Herranz-Pinto P
    Rev Clin Esp; 2011 Feb; 211(2):92-7. PubMed ID: 21376938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Moore MM; Elpern DJ; Carter DJ
    Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    Shafa S; Borum ML; Igiehon E
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
    [No Abstract]   [Full Text] [Related]  

  • 40. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.